Clinical trial

Weight Loss Effect of Akkermansia Muciniphila in Obese Patients

NCT06780007

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2025-01-21

PhaseNA

Study timeline

Study start (actual)2025-01-21Date precision: day

Registry last updated2025-09-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

28≤BMI≤35Kg/m2unresolved

Interventions

ProbioticDIETARY_SUPPLEMENT

PlaceboDIETARY_SUPPLEMENT

Sponsors & collaborators

Wecare Probiotics Co., Ltd.lead sponsor

Mapped research locations

Xi'anShaanxi, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06780007 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.